For example, simultaneous treatment with an anti-Nogo-A antibody and rehabilitation resulted in aberrant growth of residual CST axons but did not induce recovery of performance in the forelimb motor task after stroke due to excessive growth and aberrant termination patterns of rewired CST axons (Wahl et al., 2014). This evidence concerns the gene RTN4 and Stroke.